Asthma Monitor AM3
Device Facts
| Record ID | K183479 |
|---|---|
| Device Name | Asthma Monitor AM3 |
| Applicant | Eresearch Technology |
| Product Code | BZG · Anesthesiology |
| Decision Date | Oct 3, 2019 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 868.1840 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Indications for Use
The Asthma Monitor AM3 G+ is an electronic measurement device to monitor the lung function (determination of the respiratory flows and volume) with high reproducibility wherever and whenever there is a need of. The AM3 measures the flow during expiration serving for the calculation of further parameters as FEV1. The AM3 is used to monitor the respiratory status of human beings (adults and children 5 years and older) in the areas of asthma, chronic obstructive pulmonary disorder and in areas like occupational medicine, clinical trials and disease management. The patient is informed of the results by numeric values for the selected parameters (e.g. PEF, FEV1). Furthermore, a visual control unit, displayed in the form of traffic lights, allows an immediate indication of the measurement based on criteria defined by the patient's physician. The device saves the results of a measurement (always with date and time) automatically in an internal database. In addition, (symptom and medications) questionnaire functionality can be called up by the use of a software (AMOS) to record e.g. the "Quality of Life" status. When enabled, the AM3 can be programmed with a couple of questions, where the patient can then select from a couple of different answers. This information is also stored in the internal database and can be transmitted for evaluation using the software AMOS. The AM3 is designed to replace an ordinary peak flow meter, diary and pencil by a single system. The asthma monitor AM3 is intended to be used in health care, clinical and home use environments.
Device Story
Handheld electronic peak flow meter; measures PEF and FEV1 via infrared rotary flow sensor; stores measurements and patient-reported symptom/medication questionnaires in internal database. Used in home, clinical, and healthcare settings by patients and clinicians. Device replaces manual peak flow meters and paper diaries. Patients perform scheduled sessions; results displayed numerically with traffic-light visual indicators based on physician-defined thresholds. Data transmitted via 3G/TCP/IP or Bluetooth to AMOS software for clinician review. AMOS software allows configuration of sessions and thresholds; does not provide diagnosis or treatment suggestions. Benefits include improved reproducibility of lung function monitoring and automated data collection for clinical management.
Clinical Evidence
No clinical data. Bench testing only, including software verification/validation (IEC 62304), electrical safety (IEC 60601-1), EMC (IEC 60601-1-2), and spirometry accuracy per ATS/ERS 2005 standards.
Technological Characteristics
Handheld device; infrared rotary flow sensor (single patient use); Styrolution PS 454N mouthpiece; Cycoloy HC 1204HF/ROTEC ABS 1001 FR housing; 3.7V Li-ION Polymer battery; 320x240 TFT LCD; Bluetooth (BT121) and 3G (AirPrime HL8548) connectivity; USB interface. Software V&V per IEC 62304; risk management per ISO 14971.
Indications for Use
Indicated for monitoring respiratory status in adults and children 5 years and older with asthma, COPD, or in occupational medicine, clinical trials, and disease management.
Regulatory Classification
Identification
A diagnostic spirometer is a device used in pulmonary function testing to measure the volume of gas moving in or out of a patient's lungs.
Predicate Devices
- Asthma Monitor AM3 GSM (K133722)
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 3, 2019
eResearchTechnology Mingzi Deng Senior Regulatory Affairs Specialist 500 Rutherford Avenue Boston, Massachusetts 02129
Re: K183479
Trade/Device Name: Asthma Monitor AM3 G+ Regulation Number: 21 CFR 868.1840 Regulation Name: Diagnostic spirometer Regulatory Class: Class II Product Code: BZG Dated: August 29, 2019 Received: September 3, 2019
Dear Mingzi Deng:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see
https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael Ryan Division Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
## Indications for Use
510(k) Number (if known) K183479
Device Name Asthma Monitor AM3 G+
The Asthma Monitor AM3 G+ is an electronic measurement device to monitor the lung function (determination of the respiratory flows and volume) with high reproducibility wherever there is a need of. The AM3 measures the flow during expiration serving for the calculation of further parameters as FEV 1.
The AM3 is used to monitor the respiratory status of human beings (adults and children 5 years and older) in the areas of asthma, chronic obstructive pulmonary disorder and in areas like occupational medicine, clinical trials and disease management.
The patient is informed of the results by numeric values for the selected parameters (e.g. PEF, FEV ). Furthermore, a visual control unit, displayed in the form of traffic lights, allows an immediate indication of the measurement based on criteria defined by the patient's physician.
The device saves the results of a measurement (always with date and time) automatically in an internal database. In addition, (symptom and medications) questionnaire functionality can be called up by the use of a software (AMOS) to record e.g. the "Quality of Life"status.
When enabled, the AM3 can be programmed with a couple of questions, where the patient can then select from a couple of different answers. This information is also stored in the internal database and can be transmitted for evaluation using the software AMOS.
The AM3 is designed to replace an ordinary peak flow meter, diary and pencil by a single system. The asthma monitor AM3 is intended to be used in health care, clinical and home use environments.
| Type of Use ( <i>Select one or both, as applicable</i> ) | |
|----------------------------------------------------------------------------------------------------------|-----------------------------------------------|
| <span style="font-family: DejaVu Sans, sans-serif">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for ERT. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circular graphic is made up of three curved shapes in green and blue. Below the text "ERT" is the tagline "Confidence at every turn".
# GENERAL INFORMATION
| <b>1</b> | <b>Type of Submission</b><br>Special 510(k) Submission<br>Date 510(k) summary prepared: 10/03/2019 |
|----------|----------------------------------------------------------------------------------------------------|
| <b>2</b> | <b>Submitter</b> |
| | Name: eResearchTechnology GmbH |
| | Address: Sieboldstrasse3<br>D-97230 Estenfeld<br>Germany |
| | Contact person in Germany:<br>(Official Correspondent) Kristin Feld |
| | Address: eResearchTechnology GmbH<br>Sieboldstrasse 3, 97230 Estenfeld<br>Germany |
| | Phone: +49 9305 720 6377<br>FAX: +49 9305 720 60<br>E-mail kristin.feld@ert.com |
| | Contact person in the U.S.: Mingzi Deng |
| | Address eResearch Technology<br>500 Rutherford Avenue<br>Boston, MA 02129 |
Phone/Fax: +1 617 681 6010 E-mail mingzi.deng@ert.com
- 3 Establishment Registration Number
3008505660
#### 4 Common Name or Classification Name
Diagnostic Spirometer (21 CFR 868.1840, Product Code BZG)
#### 5 Trade Name
Asthma Monitor AM3 G+
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the ERT logo. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circular graphic is divided into three sections, colored blue, green, and blue. Below the text "ERT" is the tagline "Confidence at every turn".
- 6 Device Regulatory Classification
This is a Class II device
#### 7 Classification Panel and Product Code
73 Anesthesiology Part 868 Code BZG
#### Reason for Premarket Notification 8
Modification of an existing device regarding "The New 510(k) Paradigm"
- Additional data transfer capabilities via TCP/IP
- Change in operating system of device accessory software AMOS
#### 9 Legally predicate marketed device
Asthma Monitor AM3 GSM K133722 Code BZG
#### Predicate Device Company 10
eResearchTechnology GmbH
#### 11 Device Description
The Asthma Monitor AM3 G+ is a medical device (peak flow meter with symptom diary) providing following design and performance characteristics:
- Handheld device
- Battery operation
- Storing capacity of 1200 measurements
- Storing capacity of 400 sets of questionnaires (max. 20 questions each)
- Measurement Parameters: PEF and FEV1
- Accuracy Flow: ± 5% or ± 20 I/min
- . Accuracy Volume: ± 3% or ± 0.05 litre
- Wireless communication with computer/mobile device/database via Bluetooth and mobile communication (3G, TCP/IP) by using accessory software AMOS
- . Rotary Flow Sensor (single patient use)
The Asthma Monitor AM3 G+ is an instrument that combines a peak flow meter with a symptom and medication diary. This device displays questions concerning symptoms and medication to be answered twice a day and measures and evaluates the Peak Flow
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the ERT logo. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circular graphic is divided into three sections, colored light green and dark blue. Below the text "ERT" is the tagline "Confidence at every turn".
(PEF = Peak Expiratory Flow [l/min]) and FEV1 (Forced Expiratory Volume in 1 second [1]).
The AM3 G+ keeps a diary of patient measurements by automatically recording all answers and PEF measurements with the date and time in its memory. Data can be collected for approximately 100 days. Every time the patient visits the centre, the data will be downloaded by using AMOS software. Additionally the data can be exchanged to a predefined database using the 3G mobile communication module (SMS, TCP/IP).
Scheduled sessions, including questionnaire and PEF measurements, can be configured wirelessly using AMOS software, performed and stored with the AM3 G+. Following the study protocol, the patient has to carry out scheduled sessions twice a day.
In the morning and the evening session, there is a set of questions to be answered before a scheduled PEF measurement can be performed. As soon as the patient switches on the AM3 G+ for the first time during one of the time windows, the first question of the appropriate questionnaire will be displayed.
AMOS is a stand-alone software for the professional user (physician/clinical staff) for configuration, parameter processing and data display. It does not provide a diagnosis or treatment suggestions. Diagnosis and appropriate therapeutic treatments are only made by the physician. The AMOS software allows to set and adjust individual thresholds which are based on international and national standards such as ATS and ERS. They are based on the patient's individual best value which is determined by the doctor.
#### 12 Indications for Use Statement
The Asthma Monitor AM3G+ is an electronic measurement device to monitor the lung function (determination of the respiratory flows and volume) with high reproducibility wherever and whenever there is a need of. The AM3 measures the flow during expiration serving for the calculation of further parameters as FEV1.
The AM3 is used to monitor the respiratory status of human beings (adults and children 5 years and older) in the areas of asthma, chronic obstructive pulmonary disorder and in areas like occupational medicine, clinical trials and disease management.
The patient is informed of the results by numeric values for the selected parameters (e.g. PEF. FEV1). Furthermore, a visual control unit, displayed in the form of traffic lights, allows an immediate indication of the measurement based on criteria defined by the patient's physician.
The device saves the results of a measurement (always with date and time) automatically in an internal database. In addition, (symptom and medications)
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the ERT logo. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circle is divided into three sections, colored green and blue. Below the text "ERT" is the tagline "Confidence at every turn".
questionnaire functionality can be called up by the use of a software (AMOS) to record e.g. the "Quality of Life" status.
When enabled, the AM3 can be programmed with a couple of questions, where the patient can then select from a couple of different answers. This information is also stored in the internal database and can be transmitted for evaluation using the software AMOS.
The AM3 is designed to replace an ordinary peak flow meter, diary and pencil by a single system. The asthma monitor AM3 is intended to be used in health care, clinical and home use environments.
#### 13 Required Components
AM3 G+ peak flow meter measurement device Rotary Flow Sensor AMOS software User Manual
| 14 | Comparison of technological characteristics with the predicate device |
|----|-----------------------------------------------------------------------|
| | Comparison with Asthma Monitor AM3 GSM (K133722) |
| | Asthma Monitor<br>AM3GSM<br>(K133722) | Asthma Monitor<br>AM3 G+ |
|----------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications<br>for Use | The Asthma Monitor AM3 is an<br>electronic measurement device<br>to monitor the lung function<br>(determination of the respiratory<br>flows and volume) with high<br>reproducibility wherever and<br>whenever there is a need of.<br>The AM3 measures the flow<br>during expiration serving for the<br>calculation of further<br>parameters as FEV1.<br>The AM3 is used to monitor the<br>respiratory status of adult<br>human beings in the areas of<br>asthma, chronic obstructive<br>pulmonary disorder and in<br>areas like occupational<br>medicine, clinical trials and<br>disease management.<br>The patient is informed of the | The Asthma Monitor AM3G+ is<br>an electronic measurement<br>device to monitor the lung<br>function (determination of the<br>respiratory flows and volume)<br>with high reproducibility wherever<br>and whenever there is a need of.<br>The AM3 measures the flow<br>during expiration serving for the<br>calculation of further parameters<br>as FEV1.<br>The AM3 is used to monitor the<br>respiratory status of human<br>beings (adults and children 5<br>years and older) in the areas of<br>asthma, chronic obstructive<br>pulmonary disorder and in areas<br>like occupational medicine,<br>clinical trials and disease<br>management. |
| | results by numeric values for<br>the selected parameters (e.g.<br>PEF, FEV1). Furthermore, a<br>visual control unit, displayed in<br>the form of traffic lights, allows<br>an immediate indication of the<br>measurement based on criteria<br>defined by the patient's<br>physician.<br>The device saves the results of<br>a measurement (always with<br>date and time) automatically in<br>an internal database. In<br>addition, questionnaire<br>functionality can be called up by<br>the use of a software package<br>(AMOS) to record e.g. the<br>"Quality of Life" status.<br>When enabled, the AM3 can be<br>programmed with a couple of<br>questions, where the patient<br>can then select from a couple of<br>different answers. This<br>information is also stored in the<br>internal database and can be<br>transmitted for evaluation to a<br>standard PC using the software<br>package AMOS.<br>The AM3 is designed to replace<br>an ordinary peak flow meter,<br>diary and pencil by a single<br>system. Easy handling, sturdy<br>and handy design allow the<br>Asthma Monitor AM3 to be used<br>in healthcare, clinical and home<br>use environments/settings. | The patient is informed of the<br>results by numeric values for the<br>selected parameters (e.g. PEF,<br>FEV1). Furthermore, a visual<br>control unit, displayed in the form<br>of traffic lights, allows an<br>immediate indication of the<br>measurement based on criteria<br>defined by the patient's<br>physician.<br>The device saves the results of a<br>measurement (always with date<br>and time) automatically in an<br>internal database. In addition,<br>(symptom and medications)<br>questionnaire functionality can be<br>called up by the use of a software<br>(AMOS) to record e.g. the<br>"Quality of Life" status.<br>When enabled, the AM3 can be<br>programmed with a couple of<br>questions, where the patient can<br>then select from a couple of<br>different answers. This<br>information is also stored in the<br>internal database and can be<br>transmitted for evaluation using<br>the software AMOS.<br>The AM3 is designed to replace<br>an ordinary peak flow meter,<br>diary and pencil by a single<br>system. The asthma monitor AM3<br>is intended to be used in health<br>care, clinical and home use<br>environments. |
| Patient<br>population | The Asthma Monitor can be<br>used for patients from 4 years<br>on and older. | The Asthma Monitor can be<br>used for patients from 5 years<br>on and older. |
| Measurement<br>principle | Determination of respiratory<br>flow and volume via<br>exchangeable<br>infrared rotary flow sensor | Identical |
| Dimensions<br>(housing) | Length x Width x Height:<br>112 x 82 x 37 mm<br>Weight:<br>150 g (batteries included) | Identical |
| Display | LCD module<br>Size: 54.0 x 33.5 mm<br>255 x 160 dots | TFT LCD module<br>Size: 57.6 x 43.2 mm<br>320 x 240 dots |
| | Foil Key-panel (4 keys): | identical |
| Key-panel | - ESC (on/off)<br>- UP-ARROW<br>- DOWN-ARROW<br>- OK | |
| Integrated<br>mouthpiece<br>(material) | Styrolution PS 454N, single<br>patient use | identical |
| Housing of<br>the device<br>(material) | Cycoloy HC 1204HF, ROTEC<br>ABS 1001 FR | identical |
| Performance<br>(measurements) | Parameters:<br>PEF<br>FEV1<br>Accuracy:<br>PEF: $\pm$ 5% or $\pm$ 20 l/min<br>FEV1: $\pm$ 3% or $\pm$ 0.05 liter | identical |
| Interface | Serial RS 232 & USB &<br>Blue-tooth & GSM | USB & Bluetooth & 3G |
| Energy type | LI-ION Polymer battery 3.7 V,<br>1700 mAh | identical |
| Operating<br>Require-<br>ments | PC software AMOS<br>For standard PC with<br>Windows OS | AMOS App<br>Mobile application for Android<br>OS higher 6.x and Windows 10 |
| Bluetooth<br>interface | WML-C46 (Mitsumi) | BT121 (Silicon Lab) |
| Mobile<br>communicati<br>on Interface | Sierra Wireless<br>WISMO288 | Sierra Wireless<br>AirPrime HL8548 |
| Expected<br>operational<br>lifetime | 5 years | Identical |
{7}------------------------------------------------
Image /page/7/Picture/1 description: The image shows the logo for ERT. The logo consists of a circular graphic on the left and the text "ERT" on the right. Below the text is the tagline "Confidence at every turn".
{8}------------------------------------------------
Image /page/8/Picture/1 description: The image contains the logo for ERT. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circular graphic is divided into three sections, colored light green, white, and dark blue. Below the text "ERT" is the tagline "Confidence at every turn".
### Differences
The subject device, AM3 G+ is equipped with a bigger screen; and it offers further advanced options for data transfer and exchange (3G/TCPIP instead of 2G). The previously integrated GSM and BT obsolete modules are replaced with the newer 3G module and a new Bluetooth module. In addition, RS-232 interface has been removed. Data was stored, exported and exchanged wirelessly with previously PC based software AMOS (cleared in K133722). The AMOS App is now modified to run on different operating systems and platforms (Windows10 and Android OS).
{9}------------------------------------------------
Image /page/9/Picture/1 description: The image shows the logo for ERT. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circular graphic is divided into three sections, colored light green and dark blue. Below the text "ERT" is the tagline "Confidence at every turn".
#### 15 Performance Data - Summary of Device Testing
### Performance Testing
The following standards and practices were followed for development of the Asthma Monitor AM3 G+ and accessory software AMOS:
- . The device was developed and tested according to GMP Standard Operating Procedures for Medical Devices.
- . Software verification and validation was done in accordance with IEC 62304:2006 + A1:2015.
- . Risk analysis was performed according to ISO 14971:2007.
- Tests were performed to confirm that the Asthma Monitor meets the ● recommendations for accuracy and precision for Spirometry of the American Thoracic Society (ATS) according to ATS/ERS 2005 standards.
- . The electrical safety testing was performed according to IEC 60601-1:2012 and IEC 60601-1-11:2015 to demonstrate conformance with the requirements for basic safety and essential performance.
- . The Electro Magnetic Compatibility testing was performed according to IEC 60601-1-2:2014.
- . The FDA Guidance "Radio Frequency Wireless Technology in Medical Devices" issued on August 14, 2013 was considered for the 3G/BT functions and all requirements are fulfilled.
- . BT and 3G functions of the Asthma Monitor AM3 G+ were tested according to the Federal Communications Commission's rules and regulation in Title 47 of the Code of Federal Regulations to demonstrate conformity with defined frequency bands and frequencies for the different spectrum allocations.
- . The FDA Guidance "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices" from 2014 has been considered in the device design and all requirements are fulfilled.
The verification and validation activities for hardware and software were performed and the results demonstrated that the predetermined acceptance criteria were met.
### Biocompatibility
There have been no changes in material and biocompatibility. All material used is identical to the predicate device. The manufacturing process is identical to the predicate device.
{10}------------------------------------------------
Image /page/10/Picture/1 description: The image contains the logo for ERT. The logo consists of a circular graphic on the left and the text "ERT" on the right. The circular graphic is divided into three sections, colored green, light blue, and dark blue. Below the text "ERT" is the tagline "Confidence at every turn" in a smaller font.
The Rotary Flow Sensor is exactly the same as already used in the predicate device and among all Asthma Monitor devices.
No new biocompatibility testing was done, as the biocompatibility testing for the predicate device remains effective for this submission.
# Clinical Testing No clinical testing is required.
### Compliance with FDA-recognized Standards:
| Standard | Description |
|--------------------------|----------------------------------------------------------------------------|
| IEC 60601-1:2012 | Electrical Safety of Medical Devices |
| IEC 60601-1-2:2014 | Electromagnetic Compatibility of Medical Devices |
| IEC 60601-1-11:2015 | Electrical Safety of Medical Devices in the home<br>healthcare environment |
| ISO 14971:2007 | Risk Management |
| ISO 10993-1:2009 | Biological evaluation of Medical Devices |
| IEC 62304:2006 + A1:2015 | Medical Device Software - Software life-cycle processes |
#### Conclusion 16
The modified device, AM3 G+ shares the same intended use but has different technological characteristics. Based on the intended use and the results of the performance testing provided in the 510(k), the device is found to be substantially equivalent to the predicate device AM3 GSM (K133722).
